Dual-Functionalized Crescent Microgels for Selectively Capturing and Killing Cancer Cells

Area of Science:

• Biomaterials Science
• Cancer Therapy
• Drug Delivery Systems

Background:

• Selective cancer cell targeting remains a significant challenge in oncology.
• Current therapies often cause side effects due to lack of specificity.
• Novel strategies are needed for precise in situ cancer cell elimination.

Purpose of the Study:

• To develop dual-functionalized microgels for selective lung cancer cell capture and destruction.
• To investigate the efficacy of antibody-functionalized microgels containing glucose oxidase (GOX).
• To assess the in situ killing of cancer cells with minimal impact on normal cells.

Main Methods:

• Fabrication of crescent microgels using a microfluidic device.
• Functionalization of microgel inner surfaces with antibodies for cancer cell recognition.
• Incorporation of glucose oxidase (GOX) within the microgel matrix.
• Evaluation of microgel affinity, selectivity, and cancer cell killing efficiency in the presence of glucose.

Main Results:

• Microgels demonstrated high affinity and selectivity for lung cancer cells, retaining them within cavities.
• Exposure to glucose induced localized hydrogen peroxide (H2O2) production via GOX catalysis.
• A 90% selective killing of entrapped cancer cells was achieved without affecting surrounding normal cells.
• The dual-functionalized microgels showed effective in situ cancer cell elimination.

Conclusions:

• Dual-functionalized crescent microgels offer a novel strategy for targeted cancer therapy.
• The synergistic combination of capture and killing mechanisms enhances therapeutic efficacy.
• This approach holds potential for broad applications in smart materials, bioengineering, and biomedical fields.